TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers Meeting Abstract
| Authors: | Drilon, A.; Rogers, E.; Zhai, D.; Deng, W.; Zhang, X.; Lee, D.; Ung, J.; Whitten, J.; Zhang, H.; Liu, J.; Hu, T.; Zhuang, H.; Lu, Y.; Huang, Z.; Graber, A.; Zimmerman, Z.; Xin, R.; Cui, J. J.; Subbiah, V. |
| Abstract Title: | TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz244.068 |
| Language: | English |
| ACCESSION: | WOS:000491295501323 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz244.068 |
| Notes: | Meeting Abstract: 506P -- Appears on pages v190-v191 of the abstract book -- Source: Wos |
